Paul A. DiSilvestro, MD
Associate Professor
Women and Infants Hospital, Brown University
101 Dudley Street
Providence,
RI
USA
02905
Papers:
6
Clinical implications for MSI, MLH1 methylation analysis and IHC in Lynch screening for endometrial cancer patients: an analysis of 940 endometrioid endometrial cancer cases from the GOG0210 study
24
Impact of circulating tumor cells (CTCs) on overall survival among patients treated with chemotherapy plus bevacizumab for advanced cervical cancer: an NRG Oncology/Gynecologic Oncology Group study
45
Clinicopathologic features associated with defective DNA mismatch repair (MMR): a GOG0210 cohort study of 1041 endometrioid endometrial cancer cases
47
ROMA guided conservative management for women diagnosed with an ovarian cyst or pelvic mass
51
A Phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab, and veliparib (ABT-888) in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: a Gynecologic Oncology Group study
375
Concomitant anal and cervical high-risk HPV genotyping in women with and without lower genital tract dysplasia or neoplasia
389
Cancer of the uterus and treatment of incontinence (CUTI)
402
Green (IGC) fluorescence directed sentinel lymph node (SLN) biopsy in women with endometrial and cervical cancer